## Abstract ## BACKGROUND In the U.S., the majority of premenopausal patients with earlyβstage breast carcinoma are treated with adjuvant chemotherapy. However, to the authors' knowledge, there have been few formal analyses of adjuvant chemotherapy cost performed to date, especially in premenopaus
The place of adjuvant chemotherapy in early stages
β Scribed by Nina Einhorn
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- English
- Weight
- 253 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The longβterm impact of breast carcinoma and its treatment was assessed in 153 breast carcinoma survivors previously treated on a Phase III randomized trial (Cancer and Leukemia Group B [CALGB 7581]) a median of 20 years after entry to CALGB 7581. ## METHODS Survivors w
The clinical course of 117 patients who were treated for Stages IIB-IIIC sarcoma of soft tissues by the combined approach of radiation and surgery at MGH during the period 1971-1984 have been analyzed for an effect of adjuvant chemotherapy to improve clinical results. Thirty-two patients received ad